← Back to Clinical Trials
Recruiting NCT06574217

NCT06574217 Evaluation of Stepping Stones

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT06574217
Status Recruiting
Phase
Sponsor The Policy & Research Group
Condition Teen Pregnancy Prevention
Study Type INTERVENTIONAL
Enrollment 650 participants
Start Date 2024-09-16
Primary Completion 2028-03

Eligibility & Interventions

Sex All sexes
Min Age 12 Years
Max Age 22 Years
Study Type INTERVENTIONAL
Interventions
Stepping Stones (StSt)Like

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 650 participants in total. It began in 2024-09-16 with a primary completion date of 2028-03.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

The goal of this randomized trial is to learn if the Stepping Stones (StSt) intervention has a positive impact on the sexual health and relationship behaviors of sexually active youth between the ages of 12 and 22 years old who are at risk for or involved in the legal or child welfare systems. The primary research questions it aims to answer are: * Three months after being offered the intervention, does StSt impact youth's receipt of sexually transmitted infection testing in the past four months? * Nine months after being offered the intervention, does StSt impact youth's frequency of having vaginal and anal sex without condoms in the past four months? * Nine months after being offered the intervention, does StSt impact youth's perpetration of emotional abuse in the past four months? Researchers will compare participants randomized to receive StSt (treatment group) to participants randomized to receive a control condition that contains no sexual or reproductive health information (control group). Participants randomized to the treatment group will be offered StSt as an in-person or virtual, individual-based intervention delivered over four sessions during a 6-8 week period. Participants randomized to the control group will be offered a virtually delivered control condition.

Eligibility Criteria

Inclusion Criteria: * At risk for or involved in the legal or child welfare systems * Report ever having vaginal and/or anal sex and plan to have sex in the next six months * Comfortable reading, speaking, and writing in English Exclusion Criteria: * Currently trying to start a pregnancy * Currently in jail or being detained in a facility * Enrolled in an ongoing PRG-run TPP study, the No Baby No study, or the Yes \& Know study * Living in regions where the FLASH curriculum is widely implemented (King County, WA, Ramsey County, MN, Hennepin County, MN) * Identified as fraudulent (only for individuals recruited online)

Contact & Investigator

Central Contact

Hilary Demby, MPH

✉ hilary@policyandresearch.com

📞 504-865-545

Principal Investigator

Sarah Walsh, Ph.D.

PRINCIPAL INVESTIGATOR

The Policy & Research Group

Frequently Asked Questions

Who can join the NCT06574217 clinical trial?

This trial is open to participants of all sexes, aged 12 Years or older, up to 22 Years, studying Teen Pregnancy Prevention. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT06574217 currently recruiting?

Yes, NCT06574217 is actively recruiting participants. Contact the research team at hilary@policyandresearch.com for enrollment information.

Where is the NCT06574217 trial being conducted?

This trial is being conducted at New Orleans, United States.

Who is sponsoring the NCT06574217 clinical trial?

NCT06574217 is sponsored by The Policy & Research Group. The principal investigator is Sarah Walsh, Ph.D. at The Policy & Research Group. The trial plans to enroll 650 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: July 2026  ·  Data Methodology